Brought to you by 
Series D brings $10.2mm to Anulex Technologies
18 Jun 2009
Executive Summary
Anulex Technologies (devices to repair soft spinal tissues) raised $10.2mm in its Series D financing, which could bring in an additional $400k according to the Form D filing. Series C investors Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners, and Split Rock Partners all participated. The company will use part of the money for a post-market clinical trial of its Xclose tissue repair system. With the new funding, Anulex has now raised about $48.4mm.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D brings $10.2mm to Anulex Technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice